West Pharmaceutical Servs (NYSE: WST) reported quarterly earnings of $2.37 per share which beat the analyst consensus estimate of $2.08 by 13.94 percent. This is a 28.8 percent increase over earnings of $1.84 per share from the same period last year. The company reported quarterly sales of $872.300 million which beat the analyst consensus estimate of $838.586 million by 4.02 percent. This is a 13.80 percent increase over sales of $766.500 million the same period last year.